Seelos Therapeutics, Inc.
SEEL · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$37,882 | -$73,534 | -$66,048 | -$19,101 |
| Dep. & Amort. | $57 | $53 | $1,582 | $150 |
| Deferred Tax | $0 | $0 | -$1,582 | -$150 |
| Stock-Based Comp. | $3,988 | $5,073 | $8,347 | $2,044 |
| Change in WC | $12,419 | $2,783 | -$1,407 | -$4,545 |
| Other Non-Cash | -$2,494 | $4,021 | $10,113 | $689 |
| Operating Cash Flow | -$23,912 | -$61,604 | -$48,995 | -$20,913 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $6,365 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $6,365 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$7,641 | -$1,888 | -$13,551 | $147 |
| Stock Issued | $20,114 | $457 | $118,160 | $26,122 |
| Stock Repurch. | -$1,195 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $97 | -$166 | $7,458 | $45 |
| Financing Cash Flow | $11,375 | -$1,597 | $112,067 | $26,314 |
| Forex Effect | $0 | $0 | $0 | -$6,365 |
| Net Chg. in Cash | -$12,537 | -$63,201 | $63,072 | $5,401 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15,533 | $78,734 | $15,662 | $10,261 |
| End Cash | $2,996 | $15,533 | $78,734 | $15,662 |
| Free Cash Flow | -$23,912 | -$61,604 | -$48,995 | -$20,913 |